Leonurine hydrochloride

CAS No. 24735-18-0

Leonurine hydrochloride( SCM-198 hydrochloride )

Catalog No. M17452 CAS No. 24735-18-0

Leonurine (hydrochloride), a major alkaloid compound extracted from Leonurus japonicas Houtt. (Labiatae), is considered to have antitumor roles.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 46 In Stock
25MG 101 In Stock
50MG 160 In Stock
100MG 259 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Leonurine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Leonurine (hydrochloride), a major alkaloid compound extracted from Leonurus japonicas Houtt. (Labiatae), is considered to have antitumor roles.
  • Description
    Leonurine (hydrochloride), a major alkaloid compound extracted from Leonurus japonicas Houtt. (Labiatae), is considered to have antitumor roles.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SCM-198 hydrochloride
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    TLR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    24735-18-0
  • Formula Weight
    347.79
  • Molecular Formula
    C14H22ClN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 31 mg/mL; 89.13 mM
  • SMILES
    COc1cc(cc(c1O)OC)C(=O)OCCCCNC(=N)N.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mao F, et al. Leonurine hydrochloride induces apoptosis of H292 lung cancer cell by a mitochondria-dependent pathway. Pharm Biol. 2015;53(11):1684-90.
molnova catalog
related products
  • Panitumumab

    Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).

  • Naquotinib

    Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.

  • GSK-LSD1 dihydrochlo...

    GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).